InterVene, Inc.
PrivateLast Round
Series A
Oct 7, 2024
Total Funding Raised
$33.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
InterVene, Inc. operates in Healthcare & Life Sciences and is based in Redwood City, California. Its latest recorded funding round was a Series A round in October 2024.
InterVene, Inc. is a medical device company that develops catheter-based therapies for the treatment of chronic venous insufficiency and related venous diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InterVene, Inc. Comparables
Compare InterVene, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inquis Medical | 82% | |
| VentiV Scientific | 82% | |
| Endovascular Engineering, Inc. | 82% |
For institutional investors. Book with your work email.
InterVene, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 7, 2024 | ||||
| Series B | Jun 25, 2019 | ||||
| Series A | Mar 23, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InterVene, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RiverVest Venture Partners | Series B, Series A |
| North Texas Angel Network | Series A |
| 3x5 Partners | Series B |
| Launch Capital | Series A |
| Correlation Ventures | Series B |
| Green Park & Golf Ventures | Series A |
| Treo Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 108% MoM, reaching 1.6K.
- Oct 7, 2024
$13M round led by RiverVest and Treo Ventures.
For institutional investors. Book with your work email.
InterVene, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InterVene, Inc.'s valuation, stock price, and market status.
Is InterVene, Inc. a public or private company?
InterVene, Inc. is a private company.
What is the current stock price of InterVene, Inc.?
InterVene, Inc. is a private company, so its shares have no public market price. Caplight tracks InterVene, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InterVene, Inc. worth (valuation)?
Valuation information for InterVene, Inc. is not publicly available.
Can I buy InterVene, Inc. stock?
InterVene, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InterVene, Inc.'s last funding round?
InterVene, Inc.'s most recent funding round was Series A on October 7, 2024.
Who are the main investors in InterVene, Inc.?
Key investors in InterVene, Inc. include RiverVest Venture Partners, 3x5 Partners, Treo Ventures.
Will InterVene, Inc. IPO soon?
No public IPO plans have been announced for InterVene, Inc..
How can I track InterVene, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in InterVene, Inc.'s shares on secondary markets.